FDA drug center chief Janet Woodcock urged senators Wednesday (June 19) to reform the over-the-counter drug regulatory system to boost the self-care industry and save consumers money, marking the second time in the past few days that the issue has cropped up at Senate hearings on health care costs. Legislation to reform the OTC monograph process has stalled in the Senate, and Woodcock’s comments come as key Senate committees craft a legislative package to cut drug prices and reduce overall...